Wednesday, 18 July 2012
Monday, 16 July 2012
Innovative Approach towards work at IBS has always been customer and market communication centric, aimed at providing unique and innovative solutions keeping in mind your target consumer / audience. As a small company we are flexible and work in partnership with our client to build a long lasting relationship.We focus on developing end-to-end e-business solutions for our clients and have demonstrated considerable success in implementing scalable and robust solutionsIBS is spear headed by highly motivated and seasoned IT professionals and considers itself as one of the few companies who are flexible enough to offer services ranging from ecommerce solutions to brochure design, logo design, customized websites and customized web application.
IBS offers E-Commerce Web Development using custom web site design & your complete ecommerce solution from inventory management to merchandising Powered by ProStores, offer a full range of ecommerce functionality, including searchable product catalogs, shopping carts and real-time transaction processing, advanced inventory management, integration with eBay, custom shipping tables, support for instant PayPal payments, and much more.
Monday, 7 May 2012
EAHP call for medicines verification that helps single dose barcoding
The European Association of Hospital Pharmacists (EAHP), a working
community of national associations of hospital pharmacists, is calling
on the European Commission to ensure that the future pan-European
system of medicines verification facilitates, and does not hinder,
barcoding of single dose medicines administered in hospitals.
The request came in EAHP’s response to a consultation on a regulatory instrument which will set out the requirements for the unique identification of medicines throughout the European supply chain. The system is required to be introduced under the 2011 Falsified Medicines Directive and is intended to safeguard the public against counterfeit products.
EAHP emphasised the positive role barcoding of the single dose of medicine can have in terms of patient safety. It enables bedside scanning and checking of the medicine immediately prior to its administration to the patient. Studies have suggested barcoding and checking medicines in this way can reduce medication errors by as much as 40 per cent.
However EAHP warned the Commission that choices made on the specification of anti-counterfeiting systems could have unintended consequences for the possibility of pan-European barcoding of the single dose. This might include, for example, stipulating manufacturers apply a form of barcode for medicines packaging, suchas linear code, that, due to size, may not easily also be applied to single doses of medicine within blister packages. EAHP favours 2D GS1- compliant datamatrix codes for this reason.
Dr Roberto Frontini,President of the EAHP said: “Hospital Pharmacists in Europe feel very strongly about the patient safety benefits of single dose barcoding. It is therefore important that EAHP brings to the attention of all relevant policy makers in the medicines sector the advantages of introducing this approach. We also must ensure the achievement of single dose barcoding is not threatened by developments elsewhere, such as the forthcoming introduction of an anti-counterfeit medicines verification system.
He further added, “Single dose barcoding for medicines in hospitals is already a requirement in the United States, and was recommended in the 2006 report of a Group of Experts tothe Council of Europe. EAHP is stepping up its efforts to highlight the patient safety benefits and looks forward to further conversations with the Commission, and manufacturers on the topic in the months ahead.”
The request came in EAHP’s response to a consultation on a regulatory instrument which will set out the requirements for the unique identification of medicines throughout the European supply chain. The system is required to be introduced under the 2011 Falsified Medicines Directive and is intended to safeguard the public against counterfeit products.
EAHP emphasised the positive role barcoding of the single dose of medicine can have in terms of patient safety. It enables bedside scanning and checking of the medicine immediately prior to its administration to the patient. Studies have suggested barcoding and checking medicines in this way can reduce medication errors by as much as 40 per cent.
However EAHP warned the Commission that choices made on the specification of anti-counterfeiting systems could have unintended consequences for the possibility of pan-European barcoding of the single dose. This might include, for example, stipulating manufacturers apply a form of barcode for medicines packaging, suchas linear code, that, due to size, may not easily also be applied to single doses of medicine within blister packages. EAHP favours 2D GS1- compliant datamatrix codes for this reason.
Dr Roberto Frontini,President of the EAHP said: “Hospital Pharmacists in Europe feel very strongly about the patient safety benefits of single dose barcoding. It is therefore important that EAHP brings to the attention of all relevant policy makers in the medicines sector the advantages of introducing this approach. We also must ensure the achievement of single dose barcoding is not threatened by developments elsewhere, such as the forthcoming introduction of an anti-counterfeit medicines verification system.
He further added, “Single dose barcoding for medicines in hospitals is already a requirement in the United States, and was recommended in the 2006 report of a Group of Experts tothe Council of Europe. EAHP is stepping up its efforts to highlight the patient safety benefits and looks forward to further conversations with the Commission, and manufacturers on the topic in the months ahead.”
Subscribe to:
Posts (Atom)